Disease · MONDO_0007147
Comparisons in its trials47
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 20 of 47
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| JZP-110 vs Placebo: deaths from any cause | 1 of 643 | 0 of 142 | 785 | NCT02348632 | Trial comparisons |
| JZP-110 vs Placebo: serious adverse events | 27 of 643 | 0 of 142 | 785 | NCT02348632 | Trial comparisons |
| JZP-110 (Entire Study) vs Placebo (Randomized Withdrawal): deaths from any cause | 0 of 174 | 0 of 62 | 236 | NCT02348619 | Trial comparisons |
| JZP-110 (Entire Study) vs Placebo (Randomized Withdrawal): serious adverse events | 0 of 174 | 0 of 62 | 236 | NCT02348619 | Trial comparisons |
| Nasal Steroids vs Placebo: deaths from any cause | 66 of 86 | 16 of 36 | 122 | NCT02180672 | Trial comparisons |
| Nasal Steroids vs Placebo: serious adverse events | 1 of 86 | 0 of 36 | 122 | NCT02180672 | Trial comparisons |
| Active Intervention vs Placebo Intervention: deaths from any cause | 0 of 55 | 0 of 55 | 110 | NCT03919955 | Trial comparisons |
| Active Intervention vs Placebo Intervention: serious adverse events | 1 of 55 | 0 of 55 | 110 | NCT03919955 | Trial comparisons |
| Inspired Oxygen vs Sham: deaths from any cause | 0 of 46 | 0 of 45 | 91 | NCT01751971 | Trial comparisons |
| Inspired Oxygen vs Sham: serious adverse events | 0 of 46 | 0 of 45 | 91 | NCT01751971 | Trial comparisons |
| Caffeine vs Placebo: Occurence of Post Extubatory Respiratory Adverse Events. | 17 of 36 | 34 of 36 | 72 | NCT00273754 | Trial comparisons |
| Caffeine vs Placebo: Number of Children Who Developed Postextubation Adverse Respiratory Events Compared to Placebo. | 11 of 36 | 21 of 36 | 72 | NCT00273754 | Trial comparisons |
| Caffeine vs Placebo: serious adverse events | 0 of 36 | 0 of 36 | 72 | NCT00273754 | Trial comparisons |
| Nuvigil vs Control: deaths from any cause | 0 of 34 | 0 of 33 | 67 | NCT02478580 | Trial comparisons |
| Nuvigil vs Control: serious adverse events | 0 of 34 | 0 of 33 | 67 | NCT02478580 | Trial comparisons |
| Dimethyl Fumarate (Tecfidera®) Capsules vs Placebo: deaths from any cause | 0 of 44 | 0 of 21 | 65 | NCT02438137 | Trial comparisons |
| Dimethyl Fumarate (Tecfidera®) Capsules vs Placebo: serious adverse events | 1 of 44 | 1 of 21 | 65 | NCT02438137 | Trial comparisons |
| Oxytocin vs Placebo: deaths from any cause | 0 of 32 | 0 of 32 | 64 | NCT03148899 | Trial comparisons |
| Oxytocin vs Placebo: serious adverse events | 0 of 32 | 0 of 32 | 64 | NCT03148899 | Trial comparisons |
| Suvorexant (40 mg) vs Placebo: Number of Participants With an Adverse Event | 8 of 26 | 4 of 26 | 52 | NCT01300455 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0007147/comparisons